BRUSSELS (Reuters) – The European Commission said on Monday it was seeking clarification from AstraZeneca over its shortfalls in supplies to the European Union, after it sent a letter to the company in March as part of a dispute-resolution process.
“The Commission still expects the company to clarify a number of outstanding issues,” a spokesman for the EU executive told a news conference, noting there had been a meeting on the matter.
(Reporting by Francesco Guarascio @fraguarascio and Sabine Siebold)
